Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-25-337063
Filing Date
2025-12-30
Accepted
2025-12-30 16:02:48
Documents
20

Document Format Files

Seq Description Document Type Size
1 S-3 d26360ds3.htm S-3 397386
2 EX-1.2 d26360dex12.htm EX-1.2 228454
3 EX-4.3 d26360dex43.htm EX-4.3 301845
4 EX-5.1 d26360dex51.htm EX-5.1 15733
5 EX-5.2 d26360dex52.htm EX-5.2 9195
6 EX-23.1 d26360dex231.htm EX-23.1 1741
7 EX-FILING FEES d26360dexfilingfees.htm   iXBRL EX-FILING FEES 27729
8 GRAPHIC g26360g1223230535626.jpg GRAPHIC 2725
9 GRAPHIC g26360g1223230947814.jpg GRAPHIC 2742
10 GRAPHIC g26360g87b01.jpg GRAPHIC 44883
  Complete submission text file 0001193125-25-337063.txt   1184853

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT d26360dexfilingfees_htm.xml XML 10964
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-292491 | Film No.: 251614220
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)